Join our upcoming webinar to learn about the MSDA Test in a clinical setting on Dec. 13, 12:00 PM EST Register Today

News & Blog

Catch the latest

Recent Announcements & Press

July 26, 2023

Octave Bioscience Closes $30M Extension to Series B Funding, Adds New Strategic Investors Following Strong Growth and Momentum – Businesswire

June 2, 2023

Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis – Businesswire

March 21, 2023

Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis – Proteomics Clinical Applications

Octave Note

Media Library

Connecting on World MS Day

Octave Bioscience proudly partnered with Olink Proteomics for an in-depth technical webinar featuring Ferhan Qureshi, VP of Biomarker Product Development at Octave, highlighting the importance of creating connections between organizations shaping MS research.

Managing Neurodegenerative Diseases with Better Data to Improve Outcomes

Bill Hagstrom, CEO, spoke to The Bio Report about the Octave's efforts to harness novel measurements of disease to individualize care, the case we're making with payers, and why we're starting with MS.